Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
Nuno Jorge Lamas(New York Stem Cell Foundation), Paul Hofman(Inserm), Corine Bertolotto(Centre Méditerranéen de Médecine Moléculaire), Sandra Lassalle(Université Côte d'Azur), Samantha Goffinet(Université Côte d'Azur), Sacha Nahon‐Estève(Université Côte d'Azur), Arnaud Martel(Université de Sherbrooke), Adam Macocco(Université Côte d'Azur)
Cited by 62
Related Papers
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
|Cancer Research|2010|528
The Extracellular Signal–Regulated Kinase Isoform ERK1 Is Specifically Required for In Vitro and In Vivo Adipogenesis
|Diabetes|2005|334
Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)
|Genes & Development|2011|259
Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas
|Cancer Research|2010|126
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease
|Cell Death and Differentiation|2021|109